New Key Statistics Module, Z-Score and F-Score
AMEX:ATNM Key Ratios
| Market Cap $ M | 57.01 |
| Enterprise Value $ M | -24.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.27 |
| Price/Sales | 610.31 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.51 |
| Beneish M-Score | -2.12 |
| 10-y EBITDA Growth Rate % | 27.30 |
| 5-y EBITDA Growth Rate % | 25.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.52 |
| EV-to-EBITDA | 0.52 |
| PEG | -- |
| Shares Outstanding M | 31.15 |
| Net Margin (%) | -52,620.99 |
| Operating Margin % | -57,665.43 |
| Pre-tax Margin (%) | -52,620.99 |
| Quick Ratio | 8.95 |
| Current Ratio | 8.95 |
| ROA % (ttm) | -47.61 |
| ROE % (ttm) | -96.55 |
| ROIC % (ttm) | -1,262.75 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.32 |
ATNM Number of Guru Trades
ATNM Volume of Guru Trades
Gurus Latest Trades with AMEX:ATNM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:ATNM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Actinium Pharmaceuticals Inc Insider Transactions
No Available Data
News about AMEX:ATNM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers